Suppr超能文献

在死亡时特发性肺纤维化的存在存在种族和民族差异。

Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death.

机构信息

Autoimmune Lung Center and Interstitial Lung Disease Program, National Jewish Health, Denver, CO 80206, USA.

出版信息

Respir Med. 2012 Apr;106(4):588-93. doi: 10.1016/j.rmed.2012.01.002. Epub 2012 Jan 31.

Abstract

BACKGROUND

In studies of idiopathic pulmonary fibrosis (IPF), whites makeup the vast majority of subjects. Whether ethnic/racial differences in idiopathic pulmonary fibrosis occur in the general population is unknown.

METHODS

To compare the presence of IPF between ethnic/racial groups of U.S. decedents from 1989 to 2007 by using the National Center for Health Statistics database.

RESULTS

There were 251,058 U.S. decedents with IPF; 87.2% were non-Hispanic whites (White), 5.1% were non-Hispanic African American (black), 5.4% were Hispanic, and 2.2% were from other ethnic/racial groups (other). Whites coded with IPF died older than those in the other groups (77.9 years vs. 72.1 years for blacks, 75.3 years for Hispanics, and 75.6 years for others; p < 0.0001 for all pairwise comparisons). When controlling for age and for sex, compared with whites, both Hispanics and Others were more likely to be coded with IPF (OR = 1.47, 95% CI 1.44-1.49, p < 0.0001 and OR = 1.29, 95% CI 1.26-1.36, p < 0.0001 respectively), while blacks were significantly less likely to be coded with IPF (OR = 0.48, 95% CI 0.47-0.49, p < 0.0001). Among decedents with IPF, Hispanics were more likely, and blacks were less likely, than whites to die from IPF (OR = 1.24, 95% CI 1.20-1.29, p < 0.0001 and OR = 0.91, 95% CI 0.87-0.94, p < 0.0001).

CONCLUSION

From 1989 to 2007, black decedents were less-and Hispanics were more-likely than whites to die of/with IPF. Research is needed to determine if genetic differences between ethnic/racial groups explain these findings.

摘要

背景

在特发性肺纤维化(IPF)的研究中,白人占绝大多数研究对象。在普通人群中是否存在特发性肺纤维化的种族/民族差异尚不清楚。

方法

利用国家卫生统计中心数据库,比较 1989 年至 2007 年美国死者中不同种族/民族群体中特发性肺纤维化的存在情况。

结果

共有 251058 名美国死者患有特发性肺纤维化;87.2%是非西班牙裔白人(白人),5.1%是非西班牙裔非裔美国人(黑人),5.4%是西班牙裔,2.2%是其他种族/民族群体(其他)。白人编码的特发性肺纤维化患者比其他组的患者年龄更大(黑人的死亡率为 77.9 岁,西班牙裔为 75.3 岁,其他人的死亡率为 75.6 岁;所有两两比较均<0.0001)。在控制年龄和性别后,与白人相比,西班牙裔和其他人更有可能被编码为特发性肺纤维化(OR=1.47,95%CI1.44-1.49,p<0.0001 和 OR=1.29,95%CI1.26-1.36,p<0.0001),而黑人则不太可能被编码为特发性肺纤维化(OR=0.48,95%CI0.47-0.49,p<0.0001)。在患有特发性肺纤维化的死者中,西班牙裔比白人更有可能死于特发性肺纤维化(OR=1.24,95%CI1.20-1.29,p<0.0001),而黑人则比白人更不可能死于特发性肺纤维化(OR=0.91,95%CI0.87-0.94,p<0.0001)。

结论

从 1989 年到 2007 年,黑人死者死于/患有特发性肺纤维化的比例低于白人,而西班牙裔死于/患有特发性肺纤维化的比例高于白人。需要研究是否种族/民族群体之间的遗传差异解释了这些发现。

相似文献

1
Ethnic and racial differences in the presence of idiopathic pulmonary fibrosis at death.
Respir Med. 2012 Apr;106(4):588-93. doi: 10.1016/j.rmed.2012.01.002. Epub 2012 Jan 31.
2
Racial and ethnic disparities in antifibrotic therapy in idiopathic pulmonary fibrosis.
Respirology. 2023 Nov;28(11):1036-1042. doi: 10.1111/resp.14563. Epub 2023 Aug 3.
6
7
Changes in COVID-19-Associated Deaths During a Year Among Blacks and Hispanics Compared to Whites in the State of Connecticut.
J Racial Ethn Health Disparities. 2022 Oct;9(5):2049-2055. doi: 10.1007/s40615-021-01143-z. Epub 2021 Sep 28.
9
Racial and ethnic disparities in cardiovascular risk factors among stroke survivors: United States 1999 to 2001.
Stroke. 2004 Jul;35(7):1557-61. doi: 10.1161/01.STR.0000130427.84114.50. Epub 2004 Jun 10.
10
Risk of colorectal adenomas and advanced neoplasia in Hispanic, black and white patients undergoing screening colonoscopy.
Aliment Pharmacol Ther. 2012 Jun;35(12):1467-73. doi: 10.1111/j.1365-2036.2012.05119.x. Epub 2012 Apr 29.

引用本文的文献

1
Surgical lung biopsy analyses differ by race and ethnicity in interstitial lung disease.
ERJ Open Res. 2025 Jul 7;11(4). doi: 10.1183/23120541.00870-2024. eCollection 2025 Jul.
2
Health disparities and associated social determinants of health in interstitial lung disease: a narrative review.
Eur Respir Rev. 2025 Apr 2;34(176). doi: 10.1183/16000617.0176-2024. Print 2025 Apr.
3
Lack of diversity in antifibrotic trials for pulmonary fibrosis: a systematic review.
Eur Respir Rev. 2025 Mar 5;34(175). doi: 10.1183/16000617.0201-2024. Print 2025 Jan.
4
A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy.
Breast Cancer. 2025 May;32(3):607-612. doi: 10.1007/s12282-025-01680-z. Epub 2025 Feb 10.
7
Genome and Transcriptome-Wide Association Study of Fibrotic Sarcoidosis in European Americans.
Am J Respir Crit Care Med. 2024 Feb 1;209(3):334-337. doi: 10.1164/rccm.202308-1331LE.
8
Environmental Causes of Idiopathic Pulmonary Fibrosis.
Int J Mol Sci. 2023 Nov 18;24(22):16481. doi: 10.3390/ijms242216481.
9
Neighborhood Health and Outcomes in Idiopathic Pulmonary Fibrosis.
Ann Am Thorac Soc. 2024 Mar;21(3):402-410. doi: 10.1513/AnnalsATS.202304-323OC.
10
Outcomes of Lung Transplant Candidates Aged ≥70 Years During the Lung Allocation Score Era.
Ann Thorac Surg. 2024 Apr;117(4):725-732. doi: 10.1016/j.athoracsur.2023.04.046. Epub 2023 Jun 3.

本文引用的文献

1
A common MUC5B promoter polymorphism and pulmonary fibrosis.
N Engl J Med. 2011 Apr 21;364(16):1503-12. doi: 10.1056/NEJMoa1013660.
2
Familial interstitial pulmonary fibrosis: a large family with atypical clinical features.
Can Respir J. 2010 Nov-Dec;17(6):269-74. doi: 10.1155/2010/591523.
3
Rheumatoid arthritis-interstitial lung disease-associated mortality.
Am J Respir Crit Care Med. 2011 Feb 1;183(3):372-8. doi: 10.1164/rccm.201004-0622OC. Epub 2010 Sep 17.
4
Aging, antagonistic pleiotropy and fibrotic disease.
Int J Biochem Cell Biol. 2010 Sep;42(9):1398-400. doi: 10.1016/j.biocel.2010.05.010. Epub 2010 Jun 4.
5
Exposures and idiopathic lung disease.
Semin Respir Crit Care Med. 2008 Dec;29(6):670-9. doi: 10.1055/s-0028-1101277. Epub 2009 Feb 16.
6
Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer.
Am J Hum Genet. 2009 Jan;84(1):52-9. doi: 10.1016/j.ajhg.2008.11.010. Epub 2008 Dec 18.
8
A national study of chronic disease prevalence and access to care in uninsured U.S. adults.
Ann Intern Med. 2008 Aug 5;149(3):170-6. doi: 10.7326/0003-4819-149-3-200808050-00006.
9
Telomere shortening in familial and sporadic pulmonary fibrosis.
Am J Respir Crit Care Med. 2008 Oct 1;178(7):729-37. doi: 10.1164/rccm.200804-550OC. Epub 2008 Jul 17.
10
Race differences in nicotine dependence in the Collaborative Genetic study of Nicotine Dependence (COGEND).
Nicotine Tob Res. 2008 Jul;10(7):1223-30. doi: 10.1080/14622200802163266.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验